Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today reported that its Board of Directors’ Compensation Committee has granted inducement awards to nine newly hired employees. The grants, made under Mirum’s 2020 Inducement Plan, consist of non-qualified stock options to purchase an aggregate of 36,100 shares of the company’s common stock and 18,050 restricted stock units (RSUs).
The inducement awards were granted on April 10, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4), which allows for the grant of equity awards to new employees as an inducement to join the company. The stock options have an exercise price per share equal to $[PRICE], the closing price of Mirum’s common stock on the grant date. The stock options and RSUs vest over four years, with 25% vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal monthly installments over the following 36 months, subject to the employees’ continued service with the company on such vesting dates.
